0001209191-19-033719.txt : 20190531 0001209191-19-033719.hdr.sgml : 20190531 20190531182615 ACCESSION NUMBER: 0001209191-19-033719 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190530 FILED AS OF DATE: 20190531 DATE AS OF CHANGE: 20190531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brege Laura CENTRAL INDEX KEY: 0001365619 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 19871717 MAIL ADDRESS: STREET 1: C/O ONYX PHARMACEUTICALS, INC. STREET 2: 2100 POWELL STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-30 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001365619 Brege Laura C/O DYNAVAX TECHNOLOGIES 2929 7TH STREET, SUITE 100 BERKELEY CA 94710 1 0 0 0 Option (Right to Buy) 4.97 2019-05-30 4 A 0 15000 A 2026-05-29 Common Stock 15000 15000 D This option vests fully on May 30, 2020, on the one year anniversary of the grant date. Not applicable. Laura Brege, by /s/ Michael Ostrach, Attorney-in-Fact 2019-05-31